F. Torres

发表

[Definitions and diagnosis of pulmonary hypertension].

D. Badesch, M. Wilkins, M. Hoeper, 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension.

H. Ghofrani, D. Badesch, A. Frost, 2009, Journal of the American College of Cardiology.

Imatinib in pulmonary arterial hypertension, a randomized, efficacy study (IMPRES)

R. Barst, A. Peacock, G. Simonneau, 2011 .

Left Ventricular Dysfunction After Lung Transplantation for Pulmonary Arterial Hypertension.

F. Torres, S. Gupta, S. Bollineni, 2015, Transplantation proceedings.

Significance of Best Spirometry in the First Year After Bilateral Lung Transplantation: Association With 3-Year Outcomes

Song Zhang, F. Torres, A. Banga, 2019, Transplantation.

Mortality in Patients With Pulmonary Arterial Hypertension Treated With Continuous Prostanoids

K. Chin, F. Torres, S. Bartolome, 2018, Chest.

Long-Term Therapy with Oral Treprostinil in Pulmonary Arterial Hypertension Failed to Lead to Improvement in Important Physiologic Measures: Results from a Single Center

K. Chin, F. Torres, S. Bartolome, 2015, Pulmonary circulation.

Does treatment response to ambrisentan vary by pulmonary arterial hypertension severity? Implications for clinicians and for the design of future clinical trials

K. Chin, F. Torres, S. Bartolome, 2012, International journal of clinical practice.

Surgical approaches in pulmonary arterial hypertension

F. Torres, S. Bollineni, V. Kaza, 2013 .

Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study

H. Ghofrani, F. Grimminger, R. Barst, 2013, Circulation.

Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience.

L. Pacheco, F. Torres, A. Duarte, 2013, Chest.

Long-term outcomes with ambrisentan monotherapy in pulmonary arterial hypertension.

S. Matulevicius, R. Peshock, K. Chin, 2010, Journal of cardiac failure.

Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.

J. D. de Lemos, R. Peshock, J. Warner, 2008, The American journal of cardiology.

Diagnosis of pulmonary hypertension

A. Torbicki, D. Badesch, A. Frost, 2019, European Respiratory Journal.

Idiopathic and heritable pulmonary hypertension: Introduction to pathophysiology and clinical aspects

K. Chin, L. Rubin, F. Torres, 2011 .

Right atrial emptying fraction non-invasively predicts mortality in pulmonary hypertension

C. Ayers, S. Matulevicius, W. Cornwell, 2016, The International Journal of Cardiovascular Imaging.

Telomere shortening in familial and sporadic pulmonary fibrosis.

G. Raghu, C. Garcia, C. Xing, 2008, American journal of respiratory and critical care medicine.

Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey.

F. Torres, S. Lombardi, M. Kingman, 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

International Classiﬁ cation of Diseases Coding Changes Lead to Profound Declines in Reported Idiopathic Pulmonary Arterial Hypertension Mortality and Hospitalizations Implications for Database Studies

K. Chin, F. Torres, C. Glazer, 2011 .

Characteristics and Outcomes Among Patients With Early Venous Thromboembolic Events After Lung Transplant.

M. Peltz, M. Wait, F. Torres, 2020, Transplantation proceedings.

Genetic determinants of risk and survival in pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Ouwehand, 2018, bioRxiv.

Characteristics and Outcomes of Lung Transplant Candidates With Preexisting Renal Dysfunction.

B. Tanriover, F. Torres, A. Banga, 2020, Transplantation proceedings.

Association of pretransplant kidney function with outcomes after lung transplantation

B. Tanriover, F. Torres, A. Banga, 2017, Clinical transplantation.

Characteristics and outcomes among patients with need for early dialysis after lung transplantation surgery

B. Tanriover, F. Torres, A. Banga, 2017, Clinical transplantation.

Spectrum of findings on ventilation‒perfusion lung scintigraphy after lung transplantation and association with outcomes.

Song Zhang, D. Mathews, F. Torres, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Lung transplantation and gender effects on survival of recipients with cystic fibrosis.

F. Torres, C. Ahn, A. Gao, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

in Parenchymal Lung Disease

F. Torres, R. Ruggiero, S. Bartolome, 2012 .

Pulmonary hypertension in parenchymal lung disease.

F. Torres, S. Bartolome, R. Ruggiero, 2012, Heart failure clinics.

International Classification of Diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies.

K. Chin, F. Torres, C. Glazer, 2011, Chest.

Genetic determinants of risk and survival in pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Ouwehand, 2018, bioRxiv.

Ventilation perfusion pulmonary scintigraphy in the evaluation of pre-and post-lung transplant patients.

D. Mathews, F. Torres, D. Pinho, 2019, Transplantation reviews.

Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension

F. Torres, R. Ruggiero, M. Kingman, 2009, Expert opinion on pharmacotherapy.

Ambrisentan,anendothelin receptortypeA-selective endothelinreceptorantagonist, forthetreatmentofpulmonary arterialhypertension

F. Torres, R. Ruggiero, M. Kingman, 2009 .

Long-term results of the DelIVery for Pulmonary Arterial Hypertension trial

M. Gomberg-Maitland, A. Waxman, R. Frantz, 2019, Pulmonary circulation.

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.

D. Badesch, A. Frost, A. Keogh, 2012, Chest.

Nesiritide for pulmonary arterial hypertension with decompensated cor pulmonale.

F. Torres, B. Thompson, M. Kingman, 2005, Progress in cardiovascular nursing.

Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertension.

C. Ayers, M. Drazner, J. D. de Lemos, 2013, The American journal of cardiology.

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

T. Kolb, Rubina M. Khair, R. Damico, 2017, American journal of respiratory and critical care medicine.

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Stefan L. Zimmerman, Celia P. Corona-Villalobos, T. Kolb, 2015, American journal of respiratory and critical care medicine.

Community acquired respiratory viruses in lung transplant patients: incidence and outcomes.

M. Zamora, F. Torres, T. Hodges, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pharmacokinetics of Oral Treprostinil Sustained Release Tablets During Chronic Administration to Patients with Pulmonary Arterial Hypertension

J. Marier, V. Tapson, F. Torres, 2013, Journal of cardiovascular pharmacology.

Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1).

M. Allard, A. Keogh, R. Oudiz, 2017, Respiratory medicine.

Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.

M. Gomberg-Maitland, L. Rubin, J. Cerkvenik, 2016, Chest.

A case report of breakthrough infections with two SARS-CoV-2 variants in a lung transplant patient

F. Torres, A. Banga, I. Timofte, 2022, Transplantation Proceedings.

Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension.

J. D. de Lemos, K. Chin, L. Rubin, 2009, Chest.

Imatinib in Pulmonary Arterial Hypertension: C-Kit Inhibition

R. Dweik, S. Erzurum, S. Comhair, 2014, Pulmonary circulation.

An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension

S. Rosenkranz, D. Budd, C. Opitz, 2021, Pulmonary circulation.

Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure

G. Thompson, M. Gomberg-Maitland, E. Ross, 2017, Chest.

Incidence and variables associated with 30‐day mortality after lung transplantation

M. Peltz, M. Wait, F. Torres, 2019, Clinical transplantation.

Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema.

M. Zamora, F. Torres, D. Weill, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.

Quanzhen Li, T. Mohanakumar, F. Torres, 2020, Human immunology.

Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection

Song Zhang, F. Torres, A. Banga, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Characteristics and outcomes among patients with community‐acquired respiratory virus infections during the first year after lung transplantation

F. Torres, A. Banga, S. Bollineni, 2020, Clinical transplantation.

Exome Sequencing Links Mutations in PARN and RTEL1 with Familial Pulmonary Fibrosis and Telomere Shortening

S. Mane, R. Chen, J. Shay, 2015, Nature Genetics.

Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.

C. Garcia, F. Torres, J. Kozlitina, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Telomere Length of Pulmonary Fibrosis Patients Associated with Chronic Lung Allograft Dysfunction and Post-Lung Transplantation Survival

C. Garcia, F. Torres, J. Kozlitina, 2017 .

The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients.

M. Zamora, F. Torres, A. Weinberg, 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial

John W. Adams, A. Ristic, H. Farber, 2019, European Respiratory Journal.

Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation

F. Torres, S. Bartolome, 2016, Heart Failure Reviews.

Ex vivo lung perfusion: how we do it

M. Peltz, M. Wait, F. Torres, 2021, Indian Journal of Thoracic and Cardiovascular Surgery.

Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.

N. Grishin, L. Kinch, J. DiMaio, 2009, American journal of human genetics.

Parenteral prostanoids for severe Group 3 pulmonary hypertension with right ventricular dysfunction

K. Chin, F. Torres, S. Bartolome, 2021, Journal of thoracic disease.

Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.

A. Torbicki, D. Badesch, D. Khanna, 2019, Seminars in arthritis and rheumatism.

Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.

Joyce S Lee, H. Collard, I. Noth, 2014, The Lancet. Respiratory medicine.

Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

L. Mahimainathan, C. Lacelle, A. E. Clark, 2021, medRxiv.

ARIES-1: A PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF AMBRISENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

D. Badesch, A. Frost, M. Mcgoon, 2006 .

Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey.

F. Torres, S. Lombardi, M. Kingman, 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Systematic review of randomised, double‐blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension

F. Torres, Fernando Torres, 2007, International journal of clinical practice.

Evaluation of current strategies for surveillance and management of donor‐specific antibodies: Single‐center study

M. Peltz, M. Wait, C. Lacelle, 2018, Clinical transplantation.

Predictors of outcome among patients on extracorporeal membrane oxygenation as a bridge to lung transplantation

M. Peltz, M. Wait, F. Torres, 2017, Clinical transplantation.

Initial Data Report from LARIAT: A Phase 2 Study of Bardoxolone Methyl in PAH Patients on Stable Background Therapy

P. McCullough, V. Tapson, R. Oudiz, 2015 .

A Phase 2b Randomized Controlled Trial of Presatovir, an Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Lung Transplant (LT) Recipients

M. Zamora, R. Jordan, J. Gottlieb, 2018 .

Mycobacterium marinum infection in a lung transplant recipient.

M. Zamora, F. Torres, T. Hodges, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Insights From the Fifth World Health Organization Symposium Working Group: Definitions and Diagnosis of Pulmonary Hypertension

F. Torres, 2014 .

Sustained Plasma Concentrations of Treprostinil Following Chronic Dosing in Patients with Pulmonary Arterial Hypertension (PAH).

V. Tapson, F. Torres, T. Pulido, 2009, ATS 2009.

Achieving Clinical Thresholds Of Benefit With Bosentan Based Treatment: The COMPASS-3 Trial

R. Benza, H. Gupta, S. Murali, 2012, Asian Test Symposium.

Imatinib Improves Exercise Capacity and Hemodynamics at 24 Weeks as Add-on Therapy in Symptomatic Pulmonary Arterial Hypertension Patients: The IMPRES Study

H. Ghofrani, R. Barst, A. Frost, 2011 .

Insult to Injury: Development of Alveolar Hemorrhage after Initiation of Extracorporeal Membrane Oxygenation

K. Batra, F. Torres, A. Banga, 2020, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.

M. Peltz, F. Torres, L. Edwards, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Chung, 2019, Genome Medicine.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

Lisa J. Martin, Keith A. Marsolo, Ferhaan Ahmad, 2018, bioRxiv.

Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Chung, 2019, Genome Medicine.

Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation.

Quanzhen Li, T. Mohanakumar, F. Torres, 2020, Transplant immunology.

Contemporary analysis of incidence of post-operative atrial fibrillation, its predictors, and association with clinical outcomes in lung transplantation.

M. Peltz, M. Wait, F. Torres, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant Patients.

F. Torres, A. Banga, L. Terada, 2022, Transplantation.

Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19

F. Torres, A. Banga, L. Terada, 2021, The Journal of Heart and Lung Transplantation.

Predictors and outcomes of respiratory failure among lung transplant patients with COVID‐19

Song Zhang, F. Torres, A. Banga, 2021, Clinical transplantation.

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

B. Wiens, H. Ghofrani, D. Badesch, 2008, Circulation.

Hospital length of stay after lung transplantation: Independent predictors and association with early and late survival.

M. Peltz, M. Wait, F. Torres, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Long-term safety and efficacy of imatinib in pulmonary arterial hypertension.

Hyuk-Jae Chang, H. Ghofrani, R. Barst, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Definitions and diagnosis of pulmonary hypertension.

Toru Satoh, D. Badesch, M. Wilkins, 2013, Journal of the American College of Cardiology.

Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Randomized, Placebo-controlled Trial.

A. Sweatt, H. Maecker, R. Domsic, 2021, American journal of respiratory and critical care medicine.

Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?

M. Humbert, Yan Liu, M. Yacoub, 2021, American Journal of Respiratory and Critical Care Medicine.

Interaction of pre-transplant recipient characteristics and renal function in lung transplant survival.

B. Tanriover, F. Torres, A. Banga, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Treprostinil for the treatment of pulmonary arterial hypertension

L. Rubin, F. Torres, 2013, Expert review of cardiovascular therapy.

Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis.

R. Novick, F. Torres, L. Edwards, 2005, The Annals of thoracic surgery.

COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections

F. Torres, A. Banga, I. Timofte, 2022, Transplantation Proceedings.

Diaphragmatic plication among lung transplant patients: A single‐center experience

M. Peltz, M. Wait, F. Torres, 2022, Clinical transplantation.

Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID‐19

F. Torres, A. Banga, L. Terada, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Post‐infection pulmonary sequelae after COVID‐19 among patients with lung transplantation

Song Zhang, F. Torres, A. Banga, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

(1265) - Predictors of Early Mortality After Lung Transplantation in the Lung Allocation Score Era

F. Torres, A. Banga, S. Bollineni, 2017 .

Significance of Best Spirometry in the First Year After Bilateral Lung Transplantation: Association With 3-Year Outcomes.

Song Zhang, F. Torres, A. Banga, 2020, Transplantation.

ECMO Long Haulers: A Distinct Phenotype of COVID-19–Associated ARDS With Implications for Lung Transplant Candidacy

M. Peltz, M. Wait, F. Torres, 2022, Transplantation.

Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?

Yan Liu, M. Yacoub, S. Rosenkranz, 2021, American journal of respiratory and critical care medicine.

Survival in pulmonary arterial hypertension patients awaiting lung transplantation.

R. Benza, A. Frost, M. Gomberg-Maitland, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Long-Term Ambrisentan Therapy in Patients with Pulmonary Arterial Hypertension: An Analysis by WHO Functional Class.

F. Torres, 2009, ATS 2009.

Prognostic Value of Echocardiographic Variables Before and After Initiation of Parenteral Prostacyclin Therapy: An Observational Study.

E. A. Hardin, K. Chin, F. Torres, 2022, Chest.

Imatinib Safety And Efficacy: Interim Analysis Of IMPRES Extension Study In Patients With Pulmonary Arterial Hypertension

H. Ghofrani, R. Barst, H. Klose, 2012, ATS 2012.

(1239) – Characteristics and Outcome of Patients with Stroke After Lung Transplant Surgery in the Lung Allocation Score Era

F. Torres, A. Banga, S. Bollineni, 2017 .

Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival.

C. Yancy, J. DiMaio, M. Wait, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Definitions and diagnosis of pulmonary hypertension.

D. Badesch, M. Wilkins, M. Hoeper, 2013, Journal of the American College of Cardiology.

ATHENA-1: Hemodynamic Improvements Following the Addition of Ambrisentan to Background PDE5i Therapy in Patients With Pulmonary Arterial Hypertension

A. Frost, M. Allard, R. Oudiz, 2011 .

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Stefan L. Zimmerman, Celia P. Corona-Villalobos, T. Kolb, 2015, American journal of respiratory and critical care medicine.